Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Her-2 Negative Breast Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02628613
What this trial is testing

Neoadjuvant Paclitaxel Plus Epirubicin Versus Vinorelbine Plus Epirubicin in Breast Cancer With TEKT4 Variations

Who this might be right for
Breast Cancer
Fudan University 91
Testing effectiveness (Phase 2)UnknownNCT05885776
What this trial is testing

Preoperative Treatment of HR+/HER2+Breast Cancer With Pirotinib, Trastuzumab and AI Research

Who this might be right for
Breast Cancer
Tianjin Medical University Cancer Institute and Hospital 48
Post-approval studies (Phase 4)Looking for participantsNCT05452213
What this trial is testing

Comprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Resistance in Advanced Breast Cancer Patients

Who this might be right for
Breast CancerBreast NeoplasmsBreast Neoplasm Female+4 more
Institut fuer Frauengesundheit 1,000
Large-scale testing (Phase 3)Looking for participantsNCT03201861
What this trial is testing

Addition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk Women

Who this might be right for
Tubular Breast CancerMucinous Breast CancerInvasive Duct Carcinoma of Breast
RenJi Hospital 762
Testing effectiveness (Phase 2)UnknownNCT01210768
What this trial is testing

Pegylated Liposomal Doxorubicin and Cyclophosphamide in Her2-negative Stage I and II Breast Cancer Patients

Who this might be right for
Breast Cancer
TTY Biopharm 254
Not applicableUnknownNCT05893368
What this trial is testing

New Model for Integrating Person-based Care (PbC) in the Treatment of Advanced HER2-negative Breast Cancer

Who this might be right for
Advanced Breast Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 50
Not applicableEnded earlyNCT04016935
What this trial is testing

EndoPredict® Extended Endocrine Trial (EXET)

Who this might be right for
Primary Invasive Breast Cancer
Myriad Genetic Laboratories, Inc. 855
Early research (Phase 1)Study completedNCT05551897
What this trial is testing

Assess the Pharmacokinetics of Camizestrant (AZD9833) When Administered Alone and in Combination With Itraconazole

Who this might be right for
Healthy Subjects
AstraZeneca 14
Not applicableLooking for participantsNCT06518382
What this trial is testing

Tumor-microenvironment Spatial Interaction to Identify Markers of Resistance to Therapy in HER2+ Breast Cancer Patients

Who this might be right for
HER2-positive Breast Cancer
Giampaolo Bianchini 10
Not applicableStudy completedNCT03590938
What this trial is testing

Lynparza Breast Cancer Clinical Experience Investigation

Who this might be right for
Breast Cancer
AstraZeneca 111
Testing effectiveness (Phase 2)UnknownNCT00687648
What this trial is testing

Cyclophosphamide, Methotrexate, and Prednisolone With or Without Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
National Cancer Centre, Singapore 70
Large-scale testing (Phase 3)Temporarily pausedNCT05503108
What this trial is testing

Fasting Mimicking Diet Program to ImpRovE ChemoTherapy in Hormone Receptor Postive (HR+), HER2- Breast Cancer

Who this might be right for
Fasting Mimicking DietHER2-negative Breast CancerHormone Receptor-positive Breast Cancer+3 more
Leiden University Medical Center 10
Early research (Phase 1)Study completedNCT03544125
What this trial is testing

Olaparib and Durvalumab in Treating Participants With Metastatic Triple Negative Breast Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Estrogen Receptor NegativeHER2/Neu Negative+3 more
OHSU Knight Cancer Institute 3
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07782840
What this trial is testing

QL1706 Plus Neoadjuvant Endocrine Therapy in HR-Positive/HER2-Negative Breast Cancer With a Poor Response to Neoadjuvant Chemotherapy

Who this might be right for
Breast Cancer
Hebei Medical University Fourth Hospital 40
Early research (Phase 1)Ended earlyNCT05069935
What this trial is testing

FT538 in Combination With Monoclonal Antibodies in Advanced Solid Tumors

Who this might be right for
Solid Tumor, Adult
Fate Therapeutics 16
Testing effectiveness (Phase 2)Looking for participantsNCT07506876
What this trial is testing

Concurrent Neoadjuvant Chemo/Endocrine Therapy in HER2+ Breast Cancer

Who this might be right for
Breast Cancer - Infiltrating Ductal CarcinomaHER-2 Positive Breast Cancer
Legacy Health System 30
Not applicableLooking for participantsNCT06867484
What this trial is testing

Breast Re-irradiation After Second Ipsilateral Lumpectomy

Who this might be right for
Breast CancerCancerCancer of the Breast+3 more
Youssef Zeidan 114
Testing effectiveness (Phase 2)Ended earlyNCT01938833
What this trial is testing

Romidepsin and Abraxane in Treating Patients With Metastatic Inflammatory Breast Cancer

Who this might be right for
HER2-negative Breast CancerInflammatory Breast CancerMale Breast Cancer+2 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 9
Testing effectiveness (Phase 2)Study completedNCT00733408
What this trial is testing

Nab-Paclitaxel and Bevacizumab Followed By Bevacizumab and Erlotinib in Metastatic Breast Cancer

Who this might be right for
Estrogen Receptor-negative Breast CancerHER2-negative Breast CancerProgesterone Receptor-negative Breast Cancer+3 more
University of Washington 59
Not applicableStudy completedNCT02752893
What this trial is testing

Estrogen Receptor-Positive Breast Cancer Patient-Derived Xenografts

Who this might be right for
Breast Cancer
Dartmouth-Hitchcock Medical Center 10
Next Page